Showing results (1-10 of 110) with videos related to
Sort By:
Pageof 11
RSC Chemical Biology|February 2, 2026
Protein structural dynamics in covalent drug design: insights from irreversible and reversible covalent inhibitorsRuchira Basu, Steven FletcherBritish Journal of Pharmacology|March 16, 2026
Targeting protein-protein interactions with reversible covalent modalities: Non-cysteine chemistriesRuchira Basu, Steven FletcherLearning & Memory (Cold Spring Harbor, N.Y.)|June 11, 2024
Glial metabolism versatility regulates mushroom body-driven behavioral output in DrosophilaRuchira Basu, Thomas Preat, Pierre-Yves PlaçaisExpert Opinion on Therapeutic Patents|October 1, 2019
MCL-1 inhibitors - where are we now (2019)?Steven FletcherRSC Medicinal Chemistry|May 19, 2025
Razing the scaffolding: the elimination of non-catalytic functions of kinases through targeted protein degradationSarah Pogash, Steven FletcherFuture Medicinal Chemistry|November 23, 2013
Recapitulating the α-helix: nonpeptidic, low-molecular-weight ligands for the modulation of helix-mediated protein-protein interactionsMaryanna Lanning, Steven FletcherExpert Opinion on Therapeutic Patents|October 18, 2016
Mcl-1 inhibitors: a patent reviewLijia Chen, Steven FletcherACS Applied Bio Materials|January 15, 2022
Mechanistic Study on the Antibacterial Activity of Self-Assembled Poly(aryl ether)-Based Amphiphilic DendrimersRamya Kannan, Palani Prabakaran, Ruchira Basu, et al.Current Topics in Medicinal Chemistry|May 19, 2007
Protein-protein interaction inhibitors: small molecules from screening techniquesSteven Fletcher, Andrew D HamiltonBioorganic & Medicinal Chemistry Letters|June 20, 2025
Recent progress in synthetic strategies to develop potent, HDAC8-selective, small-molecule inhibitorsBrandon D Lowe, Steven FletcherPageof 11